Results 141 to 150 of about 50,832 (209)

Clinical Management of Herpes Zoster Complicated by MRSA Infection. [PDF]

open access: yesClin Cosmet Investig Dermatol
Chen X, Yu Q, Chang D, Sun L.
europepmc   +1 more source

Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Stem cells offer multifaceted therapeutic approaches for inflammatory diseases, each exhibiting distinct therapeutic properties. Hematopoietic stem cells, primarily through hematopoietic stem cell transplantation (HSCT), can effectively remodel the immune environment, showing particular promise in treating genetically linked cases.
Chen Wu   +4 more
wiley   +1 more source

O IMPACTO DA VACINAÇÃO NA PREVENÇÃO CONTRA O HERPES-ZÓSTER E A NEURALGIA PÓS-HERPÉTICA: EVIDÊNCIAS DA LITERATURA [PDF]

open access: yes
A Herpes-zóster (HZ) ocorre pela reativação do vírus varicela-zóster (VZV), após a infecção primária da Varicela. Manifesta-se por dor radicular unilateral e erupção vesicular em um dermátomo, sendo a dor neuropática uma complicação comum, especialmente ...
Batista de Souza, Maria Eduarda   +5 more
core   +1 more source

A Case of Recurrence of Severe Depressive Disorder With Flu—Neuroinflammatory Basis of Depressive Disorder

open access: yesProgress in Neurology and Psychiatry, Volume 30, Issue 1, February 2026.
ABSTRACT This case highlights a relapse of major depressive disorder in an elderly man following a flu‐like illness, with clinical features and laboratory findings supporting a possible inflammatory contribution. It emphasises the relevance of the inflammatory theory of depression, especially in individuals with late‐life depression and recent immune ...
Nauman Malik, Mohamed A. Mohamed
wiley   +1 more source

Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Filgotinib is a preferential Janus kinase 1 (JAK‐1) inhibitor registered for the treatment of ulcerative colitis (UC). Real‐world effectiveness of filgotinib, especially for difficult‐to‐treat (DTT, failure of ≥ 2 prior advanced therapies) patients, has been scarcely reported.
M. R. Naber   +17 more
wiley   +1 more source

Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care. [PDF]

open access: yesVaccines (Basel)
Fabris C   +7 more
europepmc   +1 more source

Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3‐Year J‐Post‐Marketing Surveillance

open access: yesInternational Journal of Rheumatic Diseases, Volume 29, Issue 2, February 2026.
ABSTRACT Aim This post hoc analysis of all‐case post‐marketing surveillance in Japanese patients with rheumatoid arthritis assessed risk factors for major adverse cardiovascular events (MACE), malignancies, and serious infections (SI). Methods Data of patients who received tofacitinib (≥ 1 dose) were stratified by each combination of age (< 50 years ...
Kunihiro Yamaoka   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy